Humedica Teams with BBN Technologies to Provide Highly Secure, Next-Generation Clinical Informatics Solutions to the Federal Government

* Reuters is not responsible for the content in this press release.

Wed Oct 21, 2009 8:30am EDT

Two Massachusetts firms announce strategic relationship that combines renowned
technology expertise with extensive health care experience
BOSTON and CAMBRIDGE, Mass.--(Business Wire)--
Humedica, a next-generation clinical informatics company, and BBN Technologies,
an advanced technology solutions firm, today announced they have entered into an
extensive collaborative agreement. Through this strategic relationship, Humedica
is leveraging BBN`s renowned technology expertise, including areas such as
privacy and security as well as natural language processing (NLP), to build its
advanced and highly secure novel clinical informatics platform. This multi-year
agreement also allows BBN to provide federal government agencies with health
care analytic solutions powered by Humedica`s clinical data. 

"For decades, BBN`s groundbreaking technologies have addressed some of the most
significant challenges facing the defense and intelligence communities. Applying
BBN`s knowledge base and expertise in areas such as NLP to Humedica`s leading
clinical informatics capabilities offers incredible opportunities to more
accurately understand patient care," said Kenneth Novack, chairman of Humedica
and board member of BBN Technologies. "BBN`s NLP technology has the ability to
process large quantities of unstructured documents, such as medical reports and
physician notes." 

For more than 60 years, BBN has been at the forefront of research and
development in privacy and security, with a particular focus on creating
national security standards and protecting the government`s security interests.
BBN`s Healthcare Informatics (HCI) division is now leveraging the firm`s deep
experience and innovative technologies to advance medical research and clinical
informatics. Having access to Humedica`s nationwide, de-identified longitudinal
patient database, BBN HCI is able to provide federal agencies with the
capability to improve drug and product safety monitoring and early-warning
public health surveillance efforts. For example, government agencies can more
quickly and accurately detect the potential outbreak of a disease, the onset of
a bioterrorism event, or the negative side effect of a new drug. Together,
Humedica and BBN HCI also aim to transform the way in which medical treatment
procedures and interventions are compared, assessed and monitored. 

"BBN has a long and storied history of developing solutions to solve difficult
problems with deep technology expertise. Working closely with Humedica, BBN HCI
is leveraging Humedica`s data and next-generation clinical solutions as well as
creating powerful clinical informatics applications geared specifically for
federal agencies," said Dr. Richard Upton, executive vice president, BBN
Healthcare Informatics. "Humedica offers a truly longitudinal, de-identified and
comprehensive view of patient information across the health care continuum,
including data from health systems, hospitals and ambulatory groups nationwide.
This combination of clinical and technology expertise will profoundly improve
the safety and efficiency of health care delivery." 

Through this collaboration, Humedica is applying BBN`s technology expertise
towards the ongoing development of a next-generation clinical informatics
platform. The platform`s state-of-the-art security model is built upon the
strictest standards to exceed industry privacy and security standards and is
designed to effectively handle protected health information (PHI) in a
HIPAA-compliant environment. 

"BBN has been at the forefront of research and development in the areas of
privacy and security, speech and language processing, and surveillance systems
for over half a century," said Michael Weintraub, president and CEO of Humedica.
"BBN`s long-standing record of delivering cutting-edge technology solutions to
the federal government makes them ideally positioned to provide federal agencies
health care analytic solutions utilizing Humedica`s clinical data." 

About Humedica

Humedica is a next-generation clinical informatics company that provides novel
software-as-a-service (SaaS)-based business intelligence solutions to the health
care industry. Through cutting-edge analytics, Humedica connects patient
information across varied medical settings and time periods to generate a truly
longitudinal and comprehensive view of patient care. Humedica provides its
partners and customers with the informatics solutions necessary to improve,
manage, and succeed in today`s dynamic health care market. Humedica is defining
knowledge in health care. For more information, please visit: www.humedica.com. 

About BBN Technologies/ Healthcare Informatics (HCI)

BBN Technologies is a world-renowned R&D organization with expertise spanning
speech and language processing, privacy and security systems, networking, data
mining, distributed systems, and sensor systems. BBN built one of the first
hospital information systems nearly 50 years ago automating the collection and
retrieval of patient data. Under grants from the National Institutes of Health
(NIH), BBN developed GenBank, a continually updated International database of
nucleic acid sequences, and the widely used Prophet System to enhance biomedical
research. BBN`s Healthcare Informatics (HCI) division leverages BBN`s
substantial technology expertise to transform clinical information into
actionable insights for the federal government. For more information, please
visit http://www.bbn.com/healthcare/. 

Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6078505&lang=en

Humedica
Allen Kamer, 617-475-3810
allen.kamer@humedica.com
or
fama PR
Eleanor Crow, 617-758-4143
humedica@famapr.com
or
BBN Technologies
Richard Upton, 617-873-5681
ric.upton@bbn.com
or
BBN Technologies
Joyce Kuzmin, 617-873-8120
joyce.kuzmin@bbn.com

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.